Evidence map›Paper›PMID 19563628›Full record

ArticleMalaria journal2009

Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris.

Marion Avril, Marianne J Hathaway, Megan M Cartwright, Severin O Gose, David L Narum, Joseph D Smith

Abstract read
In one paragraph

Article in Malaria journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marion AvrilSeattle Biomedical Research Institute, Seattle, Washington 98109-5219, USA. marion.avril@sbri.org
Marianne J Hathaway
Megan M Cartwright
Severin O Gose
David L Narum
Joseph D Smith

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

backgroundVAR2CSA is the main candidate for a vaccine against pregnancy-associated malaria, but vaccine development is complicated by the large size and complex disulfide bonding pattern of the protein. Recent X-ray crystallographic information suggests that domain boundaries of VAR2CSA Duffy binding-like (DBL) domains may be larger than previously predicted and include two additional cysteine residues. This study investigated whether longer constructs would improve VAR2CSA recombinant protein secretion from Pichia pastoris and if domain boundaries were applicable across different VAR2CSA alleles.

methodsVAR2CSA sequences were bioinformatically analysed to identify the predicted C11 and C12 cysteine residues at the C-termini of DBL domains and revised N- and C-termimal domain boundaries were predicted in VAR2CSA. Multiple construct boundaries were systematically evaluated for protein secretion in P. pastoris and secreted proteins were tested as immunogens.

resultsFrom a total of 42 different VAR2CSA constructs, 15 proteins (36%) were secreted. Longer construct boundaries, including the predicted C11 and C12 cysteine residues, generally improved expression of poorly or non-secreted domains and permitted expression of all six VAR2CSA DBL domains. However, protein secretion was still highly empiric and affected by subtle differences in domain boundaries and allelic variation between VAR2CSA sequences. Eleven of the secreted proteins were used to immunize rabbits. Antibodies reacted with CSA-binding infected erythrocytes, indicating that P. pastoris recombinant proteins possessed native protein epitopes.

conclusionThese findings strengthen emerging data for a revision of DBL domain boundaries in var-encoded proteins and may facilitate pregnancy malaria vaccine development.

Indexed as

AnimalsAntibodies, ProtozoanAntigens, ProtozoanCross ReactionsEpitopesFemaleMalaria, FalciparumMalaria VaccinesPichiaPlasmodium falciparumPolymorphism, GeneticPregnancyPregnancy Complications, ParasiticProtozoan ProteinsRabbitsReceptors, Cell SurfaceAntibodies, ProtozoanAntigens, ProtozoanDuffy antigen binding protein, PlasmodiumEpitopesMalaria VaccinesProtozoan ProteinsReceptors, Cell SurfaceRecombinant ProteinsVAR2CSA protein, Plasmodium falciparum

Identifiers

PMID19563628
PMCPMC2714522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.